A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure side effects of LY3971297 injection administered
under the skin in healthy participants and obese participants with high blood pressure (BP).
Blood tests will be performed to check how much LY3971297 gets into the bloodstream and how
long it takes the body to eliminate it. This is a 5-part study. The study duration will be
approximately 60 days for Part A and approximately 90 days for Parts B, C, D, and E.